Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Inex and Bayer end antibiotic research collaboration

Dec. 20, 1996

Tetracycline antibacterial agents under study at Pfizer

Dec. 20, 1996

MedImmune receives patent coverage for RespiGam

Dec. 19, 1996

Carbapenem esters revealed by SKB

Dec. 18, 1996

BMS in-licenses antifungal triazole from Eisai

Dec. 13, 1996

RSV MAb from MedImmune enters pivotal trials

Dec. 13, 1996

Favorable phase I/II data presented for Xoma's Neuprex as pediatric meningococcemia treatment

Dec. 12, 1996

New antiviral agents from CNRS

Dec. 12, 1996

Milestone reached in Cubist/BMS antiinfective drug collaboration

Dec. 11, 1996

Positive results of fomivirsen in the treatment of CMV retinitis

Dec. 11, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...